Understanding how a protein complex regulates gene translation
Mechanisms of eIF3-mediated translation regulation
This study is looking at how a protein complex called eIF3 helps control the process of making proteins from genes, which is important for healthy cell growth and development, and it hopes to find new ways to treat cancer and other diseases based on what they learn.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10887608 on NIH RePORTER |
What this research studies
This research investigates the role of the eIF3 protein complex in regulating the translation of specific mRNA transcripts, which is crucial for proper cell growth and differentiation. By exploring how eIF3 interacts with ribosomal proteins and other factors, the study aims to uncover the mechanisms behind specialized translation and its impact on cellular responses to various signals. Patients may benefit from insights gained into how these processes affect cancer and other diseases, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with cancers or genetic disorders related to cell growth and differentiation.
Not a fit: Patients with conditions unrelated to cellular translation regulation or those not affected by gene expression issues may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target the mechanisms of gene expression regulation in cancer and other diseases.
How similar studies have performed: Other research has shown promising results in understanding translation regulation, but the specific focus on eIF3's role is relatively novel.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Lee, Amy Si-Ying — Dana-Farber Cancer Inst
- Study coordinator: Lee, Amy Si-Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.